Magnesium: Benefits, Best Forms, Dosing, and Side Effects

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Health Benefits
• Recommended Dosing
• Dietary Sources
• Safety and Side Effects
• Drug Interactions
• Frequently Asked Questions
• References

Overview

Magnesium is an essential mineral involved in over 300 enzymatic reactions in the human body [1]. It serves as a cofactor for ATP production, DNA and RNA synthesis, protein synthesis, muscle contraction, nerve impulse conduction, blood glucose regulation, and blood pressure control [1][2]. Nearly all intracellular ATP exists as a magnesium-ATP complex, the biologically active form required for ATPases and kinases to catalyze phosphorylation and energy-transfer reactions [2][3]. Approximately 60% of the body's magnesium resides in bone, where it contributes to hydroxyapatite crystal structure, with the remainder distributed in muscle, soft tissue, and extracellular fluid [1].

Magnesium deficiency is widespread. Approximately 48% of the US population consumes less than the Estimated Average Requirement from food alone [1][4]. Groups at highest risk include the elderly, adolescents, individuals with chronic alcohol use, those with type 2 diabetes, and patients with gastrointestinal diseases such as Crohn's disease and celiac disease [1][5]. Subclinical deficiency is a significant public health concern because serum magnesium represents less than 1% of total body stores and is a poor marker of whole-body status [1][4][6]. Red blood cell (RBC) magnesium testing is more reflective of intracellular stores but is not routinely ordered [6].

Symptoms of deficiency progress from mild to severe [1]:

• Early: Loss of appetite, nausea, fatigue, weakness
• Moderate: Numbness, tingling, muscle cramps, personality changes
• Severe: Tetany, tremors, cardiac arrhythmias, seizures, hypocalcemia resistant to treatment until magnesium is repleted, hypokalemia

The mineral is absorbed primarily in the small intestine via two pathways: a saturable active transport system mediated by the TRPM6 ion channel (dominant at low intakes), and passive paracellular diffusion driven by electrochemical gradients (dominant at higher intakes) [2][3]. Absorption efficiency is typically 30-50% of dietary magnesium but declines as intake increases [1][2]. Taking magnesium supplements with food improves absorption (52.3% vs 45.7% fasted, a 14% relative increase), likely due to slower gastrointestinal transit [3]. Foods high in phytic acid (e.g., brown rice, whole grains) can bind magnesium and reduce absorption; white rice has minimal impact [3].

Correcting an established deficiency may take 20-40 weeks of consistent supplementation to reach steady-state body levels [3].

Forms and Bioavailability

Not all magnesium supplements are equivalent. The form determines three critical factors: elemental magnesium content (how much actual magnesium per gram of compound), bioavailability (what percentage is absorbed), and gastrointestinal tolerance (laxative effect).

Comparison Table

Form	Elemental Mg (%)	Absorption (%)	Laxative Effect	Primary Uses
Magnesium Oxide	60%	~4%	Strong	Antacid, osmotic laxative. Highest Mg per pill but poorest absorption. Poor choice for correcting deficiency [4][7][8].
Magnesium Citrate	11-16%	~30%	Moderate-High	Well-studied, reasonably absorbed. Common in clinical trials. Causes loose stools at higher doses [4][7][8].
Magnesium Glycinate (Bisglycinate)	14%	~24%	Minimal	Chelated to glycine. Good tolerance and absorption. Preferred for raising levels without GI distress [4][7][8].
Magnesium Chloride	12%	20-42%	Moderate	Better absorbed as a liquid. Absorption varies by study conditions [4][7][8].
Magnesium Aspartate	7-16%	~42%	Low-Moderate	Highest absorption in available studies. Aspartate is an excitatory amino acid; long-term safety at high doses has been questioned [4][7].
Magnesium Taurate	9%	Uncertain	Minimal	Chelated to taurine. Low elemental content but well tolerated. Taurine has independent cardiovascular benefits [4][9].
Magnesium L-Threonate (Magtein)	8%	Uncertain	Minimal	Patented form marketed for cognition. Very low elemental Mg. Animal data on brain penetration not convincingly replicated in human outcomes [4][10].
Magnesium Malate	16%	Uncertain	Low-Moderate	Chelated to malic acid (Krebs cycle intermediate). Sometimes promoted for energy. Limited human bioavailability data [4].
Magnesium Gluconate	5%	~19%+	Low-Moderate	Low elemental content. Reasonable absorption [4][7].
Magnesium Hydroxide	42%	Low	Strong	Milk of magnesia. High elemental content but poorly absorbed. Used as antacid and laxative [4].
Magnesium Sulfate (Epsom Salt)	20%	~4%	Strong	Used IV for eclampsia and torsades de pointes. Potent osmotic laxative orally. Poor oral absorption [1][4].
Magnesium Carbonate	29%	Low	Low-Moderate	Used primarily as an antacid. Poor absorption for raising systemic levels [4].

Sources for absorption and elemental data: Ranade, Am J Ther 2001; Guerrera, Am Fam Physician 2009; Firoz, Magnes Res 2001; Schuchardt, Curr Nutr Food Sci 2017 [4][7][8].

Key Principles for Form Selection

For correcting deficiency or raising levels: Glycinate (bisglycinate) and citrate have the best-supported absorption data. Glycinate is preferred when GI tolerance is a concern [4][7][8].

For cardiovascular support: Taurate combines magnesium with taurine, which has independent evidence for blood pressure reduction and endothelial function [9].

For sleep and relaxation: Glycinate is the most commonly studied form in sleep trials. The glycine component may contribute to sleep quality independently via GABA receptor modulation and core body temperature reduction [11][12]. Citrate is also reasonable. L-threonate (Magtein) does NOT appear to improve sleep per available evidence [4][13].

For cognitive function: L-threonate (Magtein) is marketed for brain health, but human evidence is minimal (see Evidence for Health Benefits). Ensuring adequate systemic magnesium via better-absorbed forms may be equally effective [4][10].

For constipation relief: Oxide and citrate have the strongest osmotic laxative effects [4].

Absorption is dose-dependent. All forms show reduced fractional absorption at higher single doses. Splitting doses (e.g., twice daily) improves total absorption [1][2].

Magnesium Orotate: A Safety Note

Magnesium orotate is sometimes marketed as a "highly bioavailable" form. However, the European Food Safety Authority (EFSA) has raised safety concerns about orotic acid due to its tumor-promoting effects at high doses [4]. This form should be avoided until safety data is more complete.

Evidence for Health Benefits

Blood Pressure

Magnesium's antihypertensive effect operates through multiple mechanisms: it acts as a natural calcium channel blocker on vascular smooth muscle, stimulates nitric oxide and prostacyclin production, and modulates endothelial function [2][14].

Overall effect: A meta-analysis of 34 RCTs (n=2,028) found that magnesium supplementation at a median dose of 368 mg/day reduced systolic blood pressure (SBP) by 2.00 mmHg (95% CI: 0.43-3.58) and diastolic blood pressure (DBP) by 1.78 mmHg (95% CI: 0.73-2.82) (Zhang et al., Hypertension, 2016) [14].

In those already on BP medications: A subsequent meta-analysis of 38 trials found substantially larger effects in hypertensive patients already taking antihypertensive drugs: SBP reduction of 7.68 mmHg and DBP reduction of 2.96 mmHg. Importantly, the effect was NOT statistically significant in untreated hypertension (Argeros et al., Hypertension, 2025) [15]. This suggests magnesium may be most valuable as an adjunct to existing antihypertensive therapy rather than as a standalone treatment.

FDA position: In January 2022, the FDA authorized a qualified health claim: "Consuming diets with adequate magnesium may reduce the risk of high blood pressure," but requires the qualifier "the evidence is inconsistent and inconclusive" [4].

Sleep

Magnesium supports sleep through activation of GABA receptors (which promote relaxation and inhibit excitatory neural signals) and by supporting the conversion of serotonin to melatonin in the pineal gland [3][11].

Older adults with insomnia: An RCT in 46 elderly subjects found that 500 mg/day of magnesium oxide for 8 weeks significantly decreased sleep onset latency (P=0.02) and increased serum melatonin and renin levels compared to placebo (Abbasi et al., J Res Med Sci, 2012) [16].

Meta-analysis in older adults: A meta-analysis of 3 RCTs (n=151 older adults) found that 320-729 mg magnesium daily reduced sleep onset latency by 17.36 minutes (95% CI: -27.27 to -7.44, P=0.0006). The most common side effect was soft stools (Mah & Piber, BMC Complement Med Ther, 2021) [17].

Magnesium bisglycinate: An RCT of 155 participants found that 250 mg elemental magnesium as bisglycinate for 4 weeks modestly reduced insomnia severity (ISI score), with a small effect size (Cohen's d=0.2). Greater benefit was observed in those with lower baseline magnesium intake (Schuster et al., Nat Sci Sleep, 2025) [18].

Magnesium L-threonate (Magtein) for sleep: An industry-funded RCT (n=80) of 1 g/day Magtein for 21 days reported improved deep sleep and REM sleep scores via Oura ring and improved daytime functioning (Hausenblas et al., Sleep Med X, 2024) [13]. However, the study was small, short, industry-funded, has a published corrigendum, and questionnaire-based sleep measures did not consistently improve. Per ConsumerLab's assessment, Magtein does NOT appear to reliably improve sleep [4].

Deficiency and sleep disorders: Magnesium deficiency is NOT associated with insomnia per se but IS associated with approximately 3-fold increased risk of sleep apnea [4].

Practical recommendation: For sleep, citrate or bisglycinate in the 250-300 mg elemental range, taken 1-2 hours before bed, has the best evidence [4][16][17][18].

Cognitive Function

Calcium-to-magnesium ratio: A study of 250 adults aged 65+ (Vanderbilt University) found that reducing the dietary calcium-to-magnesium ratio improved cognition by 9.1% via APOE gene methylation (Zhu et al., J Alzheimers Dis, 2020) [19]. The ratio should not be reduced below 1.7.

Long-term observational data: A 20-year follow-up of 6,473 women aged 70+ found that those consuming 257-317 mg/day of magnesium had 37% lower risk of mild cognitive impairment compared to those with lower intakes (Lo et al., BMJ Open, 2019) [20].

Magnesium L-threonate (Magtein): Three human studies exist, all showing minimal benefit. The original animal study (Slutsky et al., Neuron, 2010) demonstrated enhanced synaptic plasticity and memory in rats [10], but the dose used was equivalent to approximately 7 g/day in humans — 20 times the tolerable upper limit. Human trials have not convincingly replicated these findings. Given L-threonate's very low elemental magnesium content (8%), achieving adequate systemic magnesium via better-absorbed forms (glycinate, citrate) may be equally or more effective for brain health at a fraction of the cost [4][10].

Synthesis: The mechanistic rationale is strong (NMDA receptor function, synaptic plasticity, neuroinflammation reduction), but clinical trial evidence does not yet support recommending magnesium specifically for cognitive enhancement over general adequacy [2][4].

Diabetes and Insulin Resistance

Magnesium is required for insulin receptor tyrosine kinase activity and acts as a second messenger for insulin signaling. Deficiency impairs both insulin secretion and insulin sensitivity [1][2][21].

Prediabetes with low magnesium: An RCT of hypomagnesemic adults with prediabetes found that 382 mg/day of magnesium chloride for 4 months resulted in 50.8% of participants improving their glucose status versus only 7% in the placebo group. Fasting glucose fell to 86.9 vs 98.3 mg/dL (Guerrero-Romero et al., Diabetes & Metabolism, 2015) [21].

Metabolic syndrome with low magnesium: The same research group found that after 4 months of 382 mg magnesium chloride, only 48% of the magnesium group still met criteria for metabolic syndrome versus 77.5% of placebo (Rodriguez-Moran et al., Adv Chronic Kidney Dis, 2018) [22].

Established type 2 diabetes: An RCT in 14 patients with already-treated type 2 diabetes and low magnesium found that 360 mg magnesium gluconate did NOT improve insulin sensitivity (Drethen et al., Diabetologia, 2023) [23].

Conclusion: Magnesium supplementation helps prediabetes and metabolic syndrome when magnesium levels are low. It does NOT appear to benefit already-treated type 2 diabetes [4][21][22][23].

Bone Health

Approximately 60% of body magnesium resides in bone, where it contributes to the hydroxyapatite crystal structure and regulates osteoblast and osteoclast activity [1][2].

Bone mineral density: An analysis of approximately 2,000 adults aged 70-79 found that meeting the RDA for magnesium was associated with 2% higher bone mineral density (BMD) in white women at the hip (Ryder et al., J Am Geriatr Soc, 2005) [24].

Fracture risk: A study of approximately 3,000 US adults with 8-year follow-up found that the highest magnesium intake was associated with 53% lower fracture risk in men and 62% lower fracture risk in women. Women meeting the RDA had 27% lower fracture risk (Veronese et al., Br J Nutr, 2017) [25].

Mechanism: Magnesium deficiency promotes inflammation and oxidative stress, impairs parathyroid hormone secretion, and reduces active vitamin D conversion, all of which contribute to bone loss. Severe magnesium deficiency causes hypocalcemia resistant to calcium and vitamin D supplementation until magnesium is repleted [1][2].

Exercise and Muscle Recovery

Magnesium is essential for muscle contraction and relaxation via its role in calcium transport (SERCA pump function), ATP hydrolysis, and electrolyte balance. Nearly all intracellular ATP exists as a magnesium-ATP complex [2][3].

Intense exercise depletes magnesium through sweat, increasing requirements by an estimated 10-20% in athletes. Urinary magnesium excretion can also rise by up to 30% after strenuous exercise [3][26].

Muscle soreness in low-Mg individuals: An RCT in low-magnesium runners found that 500 mg magnesium oxide for 7 days reduced muscle soreness by 32% at 24 hours and 53% at 72 hours versus placebo (Steward et al., Nutrients, 2019) [26].

Glycinate for DOMS: An RCT in 22 college students found that 350 mg magnesium glycinate for 8 days modestly reduced delayed-onset muscle soreness (Reno et al., J Strength Cond Res, 2020) [27].

Performance in adequate-Mg adults: An RCT of 15 adults with adequate magnesium levels found that 300 mg magnesium chloride actually WORSENED cycling performance (Bomar et al., Nutrients, 2025) [28]. The mechanism may relate to magnesium's muscle-relaxing properties interfering with optimal contraction force.

Elderly women: An RCT of approximately 100 elderly women found that 300 mg magnesium oxide for 12 weeks improved walking speed and chair-rise performance (Veronese et al., AJCN, 2014) [29].

Practical implication: Magnesium supplementation for exercise recovery appears beneficial only if intake or levels are low. Athletes should ensure adequate dietary magnesium but should not megadose, as supplementation in replete individuals may worsen performance [26][27][28].

Leg Cramps

Despite being one of the most commonly cited reasons for taking magnesium, the evidence is disappointing.

A Cochrane systematic review concluded that magnesium supplementation is "unlikely to provide meaningful clinical benefit" for skeletal muscle cramps regardless of form or dose (Garrison et al., Cochrane Database Syst Rev, 2020) [30].

A subsequent RCT in Finland (n=109) confirmed that 250 mg magnesium hydrochloride for 4 weeks did NOT reduce cramp frequency (Kuusipalo et al., Trials, 2026) [31].

Pregnancy cramps: Results are mixed, but the overall meta-analysis indicates magnesium is NOT effective for pregnancy-related leg cramps (Liu et al., Taiwan J Obstet Gynecol, 2021) [32].

Synthesis: The widespread belief that magnesium helps leg cramps exceeds the evidence. Cramps may respond to magnesium only when deficiency is the underlying cause, and even then, the evidence is weak [4][30][31].

Migraine Prevention

Positive evidence: An RCT of 600 mg magnesium citrate daily in divided doses reduced migraine frequency (Koseoglu et al., Magnes Res, 2008) [33]. Another trial using 600 mg trimagnesium dicitrate found a 41.6% reduction in migraine frequency versus 15.8% for placebo (Peikert et al., Cephalalgia, 1996) [34].

Negative evidence: A trial combining 300 mg magnesium citrate/oxide with riboflavin and feverfew was NOT better than placebo (Maizels et al., Headache, 2004) [35].

Practical note: Most positive migraine trials used 600 mg/day, well above the 350 mg supplement UL. GI side effects (diarrhea) are common at these doses. This indication should be discussed with a healthcare provider [4][33][34].

Depression

Epidemiological data: Higher dietary magnesium intake has been inversely associated with depression risk in several prospective studies [36][37].

Interventional evidence: The best evidence comes from a small RCT (n=60) in Iran finding that 250 mg magnesium oxide twice daily produced modest reductions in depression scores (Rajizadeh et al., 2017) [38]. However, no well-designed, placebo-controlled RCT has confirmed clear antidepressant effects [4].

Mechanism: Magnesium modulates the hypothalamic-pituitary-adrenal (HPA) axis, blocks NMDA receptors (similar to the mechanism of ketamine), and regulates serotonin and other neurotransmitters [2][36].

Synthesis: The mechanistic rationale is strong and epidemiological associations are consistent, but the interventional evidence remains preliminary. Correcting deficiency is reasonable in depressed patients, but magnesium should not be used as a substitute for established treatments [4][36].

Cardiovascular Disease (Beyond Blood Pressure)

Arrhythmia: Intravenous magnesium is standard of care for torsades de pointes. Low serum magnesium is an independent risk factor for atrial fibrillation (Khan et al., Circulation, 2013) [39].

Heart failure: Hypomagnesemia is common in heart failure patients (due to diuretic use) and is associated with worse outcomes (Adamopoulos et al., Int J Cardiol, 2009) [40].

Endothelial function: Magnesium supplementation improves flow-mediated dilation in magnesium-deficient individuals, likely via reduced oxidative stress and increased nitric oxide bioavailability [2][14].

Preeclampsia and Pregnancy

Magnesium sulfate is the gold-standard treatment for eclamptic seizures and severe preeclampsia, administered intravenously (Magpie Trial, Lancet, 2002) [41]. This is one of the most well-established clinical uses of magnesium in medicine. Magnesium needs increase during pregnancy to 350-360 mg/day [1].

Recommended Dosing

Recommended Dietary Allowances (RDAs)

From the NIH Office of Dietary Supplements [1]:

Age Group	Male (mg/day)	Female (mg/day)
14-18 years	410	360
19-30 years	400	310
31-50 years	420	320
51+ years	420	320
Pregnancy	--	350-360
Lactation	--	310-320

Tolerable Upper Intake Level (UL)

The UL for supplemental magnesium (not including food sources) is 350 mg/day for adults [1]. This limit is based on the onset of osmotic diarrhea, not systemic toxicity. Magnesium from food does not count toward this limit because food-source magnesium is absorbed more slowly and does not cause osmotic diarrhea at normal intake levels.

Practical Dosing by Indication

• General supplementation (to fill dietary gaps): 200-350 mg elemental magnesium per day, ideally split into two doses for better absorption [1][4].
• Blood pressure support: 300-500 mg/day. Most positive trials used 350-450 mg/day [14][15].
• Sleep: 250-300 mg elemental, taken 1-2 hours before bed. Glycinate (bisglycinate) or citrate [4][16][17][18].
• Migraine prevention: 400-600 mg/day in divided doses (exceeds UL; discuss with healthcare provider) [33][34].
• Prediabetes/insulin resistance with low magnesium: 250-400 mg/day [21].
• Muscle recovery (athletes with low Mg): 300-500 mg/day during heavy training periods [26][27].

Dr Brad Stanfield's MicroVitamin includes 126 mg of elemental magnesium as magnesium taurate — a form chosen for its cardiovascular benefits (taurine has independent evidence for blood pressure reduction and endothelial function) and excellent gastrointestinal tolerance. This dose contributes meaningfully toward the RDA without approaching the supplement UL, consistent with a food-first approach that uses supplementation to fill common dietary gaps.

For dedicated sleep support, Dr Brad Stanfield's Sleep formula includes magnesium glycinate — the form with the best evidence for sleep quality — combined with low-dose melatonin (0.3 mg) and glycine (2,400 mg). The glycine in both the magnesium chelate and the standalone ingredient supports sleep through GABA receptor modulation and core body temperature reduction [11][12].

How to Read a Supplement Label

The weight of the magnesium compound and the weight of elemental magnesium are different. This is the single most common source of consumer confusion.

• 1,000 mg magnesium glycinate = approximately 140 mg elemental magnesium
• 500 mg magnesium oxide = approximately 300 mg elemental magnesium (but only ~4% absorbed = ~12 mg utilized)
• 1,000 mg magnesium citrate = approximately 110-160 mg elemental magnesium

Look for "elemental magnesium" or check the "% Daily Value" on the Supplement Facts label. If a product lists 420 mg at 100% DV, it contains 420 mg elemental magnesium regardless of compound weight [4].

Dietary Sources

Magnesium is found in a wide range of foods. Green leafy vegetables, legumes, nuts, seeds, and whole grains are the richest sources [1].

Top Food Sources

Food	Serving	Magnesium (mg)	% DV (420 mg)
Pumpkin seeds (pepitas)	1 oz (28g)	156	37%
Chia seeds	1 oz (28g)	111	26%
Almonds, dry roasted	1 oz (28g)	80	19%
Spinach, boiled	1/2 cup	78	19%
Cashews, dry roasted	1 oz (28g)	74	18%
Black beans, cooked	1/2 cup	60	14%
Dark chocolate (60-90%)	1 oz (28g)	50	12%
Brown rice, cooked	1/2 cup	42	10%
Plain yogurt	8 oz	42	10%
Banana	1 medium	32	8%

Source: NIH ODS, USDA FoodData Central [1][42].

Practical Notes on Dietary Magnesium

• Refining grains removes magnesium. White bread has approximately 25% of the magnesium found in whole wheat bread. White rice has roughly half the magnesium of brown rice [1].
• Water can be a significant source. Tap water magnesium content varies widely (1-120 mg/L) depending on the source. Hard water areas can contribute meaningfully to daily intake [1].
• Cooking reduces magnesium content, particularly boiling (magnesium leaches into cooking water). Steaming and roasting preserve more magnesium [1].
• Phytic acid in whole grains and legumes can bind magnesium and reduce absorption. Soaking, sprouting, or fermenting these foods reduces phytate content [3].
• Food-first approach: Meeting the RDA through diet alone is achievable with consistent intake of nuts/seeds, leafy greens, legumes, and whole grains (providing 400+ mg/day). However, the typical Western diet falls short, which is why supplementation is common [1][4].

Safety and Side Effects

Common Side Effects

The primary side effect of oral magnesium supplementation is osmotic diarrhea, caused by unabsorbed magnesium drawing water into the intestinal lumen [1][4]. Risk varies by form:

• High laxative risk: Oxide, sulfate, hydroxide
• Moderate laxative risk: Citrate (especially above 300 mg elemental), chloride, aspartate, malate, gluconate (at higher doses)
• Low/no laxative risk: Glycinate/bisglycinate, taurate, threonate

Other reported side effects include nausea, abdominal cramping, and bloating, typically at doses above 350 mg elemental from supplements [1].

Toxicity (Hypermagnesemia)

Magnesium toxicity from oral supplements is rare in individuals with normal kidney function because the kidneys efficiently excrete excess magnesium [1]. However, hypermagnesemia can occur with:

• Renal impairment: Reduced magnesium clearance makes supplementation potentially dangerous. Patients with eGFR <30 mL/min should avoid magnesium supplements unless monitored [1][43].
• Massive oral doses from magnesium-containing laxatives or antacids used in excess.
• Intravenous administration errors.

Symptoms of hypermagnesemia progress with severity [1][43]:

• Mild (1.7-2.3 mmol/L): Nausea, flushing, lethargy
• Moderate (2.3-5.0 mmol/L): Hypotension, loss of deep tendon reflexes, ECG changes
• Severe (>5.0 mmol/L): Respiratory paralysis, cardiac arrest

Special Populations

Pregnancy: Magnesium needs increase to 350-360 mg/day. Supplementation is generally safe. IV magnesium sulfate is standard treatment for preeclampsia [1][41].

Elderly: At higher risk of deficiency due to reduced absorption, lower dietary intake, and increased use of medications (PPIs, diuretics) that deplete magnesium [1][4].

Kidney disease: Supplementation is contraindicated or requires close monitoring in advanced chronic kidney disease (CKD stage 4-5 / eGFR <30) [1][43].

Drug Interactions

Magnesium supplements can interact with numerous medications. The interactions fall into two categories: magnesium reducing drug absorption (chelation), and drugs affecting magnesium levels.

Magnesium Reduces Drug Absorption

These medications should be separated from magnesium supplements [1][4][44]:

Drug Class	Examples	Separation Time	Notes
Bisphosphonates	Alendronate, risedronate	2+ hours	Chelation reduces bisphosphonate absorption dramatically [4][44]
Tetracycline antibiotics	Doxycycline, minocycline	1h before or 2h after	Forms insoluble complexes [4][44]
Fluoroquinolone antibiotics	Ciprofloxacin, levofloxacin	2h before or 6h after	Reduces ciprofloxacin absorption up to 90% [4][44]
Levothyroxine	Synthroid, Levoxyl	2-4 hours (4h for antacid forms)	ALL forms of magnesium affect absorption [4][44]
Statins (rosuvastatin)	Crestor	2+ hours	Antacid forms (oxide, hydroxide) reduce rosuvastatin absorption by 54%. Non-antacid forms (glycinate, taurate) are less likely to cause this interaction [4][44]
Sotalol	Betapace	2+ hours	Magnesium reduces blood levels [4]
Gabapentin	Neurontin	2+ hours	Magnesium hydroxide reduces bioavailability by 20% [4]

Drugs That Affect Magnesium Levels

Drug Class	Effect on Magnesium	Clinical Implication
Proton pump inhibitors (PPIs)	Deplete	Long-term use (>1 year) can cause clinically significant hypomagnesemia. FDA issued a safety communication in 2011 [1][4][45].
Loop diuretics	Deplete	Furosemide, bumetanide increase renal magnesium excretion. Supplementation often necessary [1][4].
Thiazide diuretics	Mild depletion	Less magnesium-wasting than loop diuretics but can contribute to deficiency with prolonged use [1].
Potassium-sparing diuretics	May increase	Amiloride, spironolactone reduce renal magnesium excretion. Do NOT combine amiloride with magnesium supplements [4][44].
SGLT2 inhibitors	May increase	Empagliflozin, dapagliflozin may modestly increase serum magnesium. Monitor if supplementing [4][44].
Digoxin	Bidirectional	Magnesium deficiency increases digoxin toxicity risk. Maintain adequate levels in digoxin users [1][4].
High-dose zinc	May impair Mg	Very high doses of zinc supplements can interfere with the body's ability to absorb and regulate magnesium [1].

Frequently Asked Questions

Which form of magnesium is best?

There is no single best form. For general supplementation and correcting deficiency, glycinate (bisglycinate) offers the best balance of absorption and tolerance. For sleep, glycinate or citrate. For cardiovascular support, taurate. For constipation, oxide or citrate. For migraine prevention, citrate has the most trial data [4][7][8].

Can I take too much magnesium?

The upper limit for supplemental magnesium is 350 mg/day for adults. The main risk of excess is diarrhea, not systemic toxicity, in individuals with normal kidney function. Those with kidney disease (eGFR <30) should avoid magnesium supplements unless monitored [1][43].

Should I take magnesium with food?

Yes. Taking magnesium with meals improves absorption by approximately 14% and reduces gastrointestinal side effects [3].

How long does magnesium take to work?

Benefits for sleep may appear within 1-4 weeks. Blood pressure effects typically emerge over 4-12 weeks. Correcting an established deficiency may take 20-40 weeks [3][14][16][17].

Is magnesium L-threonate (Magtein) worth the premium price?

The evidence does not support it. Magtein provides only 8% elemental magnesium, human cognitive trials have shown minimal benefit, and it has failed to reliably improve sleep. The original animal data used doses equivalent to 20 times the human upper limit. Better-absorbed forms like glycinate provide more elemental magnesium at lower cost [4][10][13].

Does magnesium help with leg cramps?

Probably not. A Cochrane systematic review concluded that magnesium supplementation is unlikely to provide meaningful benefit for muscle cramps regardless of form or dose [30][31].

Do Epsom salt baths or topical magnesium creams work?

Evidence for transdermal magnesium absorption is weak. A placebo-controlled study found no statistically significant increase in blood magnesium levels from applying magnesium chloride cream to the skin daily for two weeks [4]. Magnesium "oil" sprays, lotions, and bath soaks lack rigorous evidence of meaningful systemic absorption. Any perceived benefits may be attributable to the relaxation effects of warm baths or massage rather than magnesium uptake [4].

Can I combine different forms of magnesium?

Yes, provided total elemental magnesium from supplements stays within the 350 mg/day UL. A common approach is one form in the morning and another at night [4].

References

1. National Institutes of Health, Office of Dietary Supplements. "Magnesium — Health Professional Fact Sheet." Updated June 2, 2022. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

2. de Baaij JHF, Hoenderop JGJ, Bindels RJM. "Magnesium in Man: Implications for Health and Disease." Physiol Rev. 2015;95(1):1-46. doi: 10.1152/physrev.00012.2014

3. Grokipedia. "Magnesium supplements." https://grokipedia.com/page/Magnesium_supplements

4. ConsumerLab. "Magnesium Supplements Review." Accessed 2025. https://www.consumerlab.com/reviews/magnesium-supplements-review/magnesium/

5. Rosanoff A, Weaver CM, Rude RK. "Suboptimal magnesium status in the United States: are the health consequences underestimated?" Nutr Rev. 2012;70(3):153-164. doi: 10.1111/j.1753-4887.2011.00465.x

6. Costello RB, Elin RJ, Rosanoff A, et al. "Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium." Adv Nutr. 2016;7(6):977-993. doi: 10.3945/an.116.012765

7. Firoz M, Graber M. "Bioavailability of US commercial magnesium preparations." Magnes Res. 2001;14(4):257-262. PMID: 11794633

8. Schuchardt JP, Hahn A. "Intestinal Absorption and Factors Influencing Bioavailability of Magnesium — An Update." Curr Nutr Food Sci. 2017;13(4):260-278.

9. Shrivastava P, Choudhary R, Nirmalkar U, et al. "Magnesium taurate attenuates progression of hypertension and cardiotoxicity." J Drug Target. 2019;27(3):321-331. doi: 10.1080/1061186X.2018.1519658

10. Slutsky I, Abumaria N, Wu LJ, et al. "Enhancement of Learning and Memory by Elevating Brain Magnesium." Neuron. 2010;65(2):165-177. doi: 10.1016/j.neuron.2009.12.026

11. Bannai M, Kawai N. "New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep." J Pharmacol Sci. 2012;118(2):145-148. doi: 10.1254/jphs.11R04FM

12. Kawai N, Sakai N, Okuro M, et al. "The Sleep-Promoting and Hypothermic Effects of Glycine are Mediated by NMDA Receptors in the Suprachiasmatic Nucleus." Neuropsychopharmacology. 2015;40(6):1405-1416. doi: 10.1038/npp.2014.326

13. Hausenblas HA, et al. "Magnesium L-Threonate and Sleep: A Double-Blind Placebo-Controlled Trial." Sleep Med X. 2024. doi: 10.1016/j.sleepx.2024.100101

14. Zhang X, Li Y, Del Gobbo LC, et al. "Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials." Hypertension. 2016;68(2):324-333. doi: 10.1161/HYPERTENSIONAHA.116.07664

15. Argeros T, Karageorgos G, et al. "Magnesium Supplementation and Blood Pressure in Hypertensive Patients on Antihypertensive Therapy: A Meta-Analysis." Hypertension. 2025. doi: 10.1161/HYPERTENSIONAHA.124.24417

16. Abbasi B, Kimiagar M, Sadeghniiat K, et al. "The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial." J Res Med Sci. 2012;17(12):1161-1169. PMID: 23853635

17. Mah J, Piber D. "Magnesium and Sleep in Older Adults: A Systematic Review and Meta-Analysis." BMC Complement Med Ther. 2021. doi: 10.1186/s12906-021-03297-z

18. Schuster AK, et al. "Effect of Magnesium Bisglycinate Supplementation on Insomnia Severity: A Randomized Double-Blind Placebo-Controlled Trial." Nat Sci Sleep. 2025. doi: 10.2147/NSS.S505199

19. Zhu M, et al. "Calcium and Magnesium Intakes and Cognitive Decline in Older Adults: The Cache County Study." J Alzheimers Dis. 2020;73(2):689-700. doi: 10.3233/JAD-190745

20. Lo K, et al. "Dietary magnesium intake and risk of mild cognitive impairment in women." BMJ Open. 2019.

21. Guerrero-Romero F, Simental-Mendia LE, Hernandez-Ronquillo G, Rodriguez-Moran M. "Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance." Diabetes & Metabolism. 2015;41(3):202-207. PMID: 25937055

22. Rodriguez-Moran M, et al. "Oral magnesium supplementation and metabolic syndrome." Adv Chronic Kidney Dis. 2018.

23. Drethen T, et al. "Effect of Magnesium Supplementation on Glycemic Control in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Trial." Diabetologia. 2023. doi: 10.1007/s00125-023-06003-9

24. Ryder KM, Shorr RI, Bush AJ, et al. "Magnesium intake from food and supplements is associated with bone mineral density in healthy older white women." J Am Geriatr Soc. 2005;53(11):1875-1880. doi: 10.1111/j.1532-5415.2005.53561.x

25. Veronese N, Stubbs B, Solmi M, et al. "Dietary magnesium intake and fracture risk: data from a large prospective study." Br J Nutr. 2017;117(11):1570-1576. doi: 10.1017/S0007114517001350

26. Steward CJ, Zhou Y, Bhatti G, et al. "Magnesium Supplementation and Exercise Recovery." Nutrients. 2019;11(12):2923. doi: 10.3390/nu11122923

27. Reno AM, et al. "Effects of Magnesium Supplementation on Muscle Soreness and Performance." J Strength Cond Res. 2020.

28. Bomar ME, et al. "Magnesium Supplementation and Exercise Performance in Replete Adults." Nutrients. 2025. doi: 10.3390/nu17020284

29. Veronese N, et al. "Effect of oral magnesium supplementation on physical performance in healthy elderly women." Am J Clin Nutr. 2014;100(3):974-981.

30. Garrison SR, Korownyk CS, Kolber MR, et al. "Magnesium for skeletal muscle cramps." Cochrane Database Syst Rev. 2020;9(9):CD009402. doi: 10.1002/14651858.CD009402.pub3

31. Kuusipalo T, et al. "Magnesium supplementation for leg cramps: A randomized controlled trial." Trials. 2026.

32. Liu CF, et al. "Magnesium supplementation during pregnancy for leg cramps: A meta-analysis." Taiwan J Obstet Gynecol. 2021.

33. Koseoglu E, Talaslioglu A, Gonul AS, Kula M. "The effects of magnesium prophylaxis in migraine without aura." Magnes Res. 2008;21(2):101-108. PMID: 18705538

34. Peikert A, Wilimzig C, Kohne-Volland R. "Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study." Cephalalgia. 1996;16(4):257-263. doi: 10.1046/j.1468-2982.1996.1604257.x

35. Maizels M, et al. "A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis." Headache. 2004.

36. Serefko A, Szopa A, Wlaz P, et al. "Magnesium in depression." Pharmacol Rep. 2013;65(3):547-554. doi: 10.1016/S1734-1140(13)71032-6

37. Tarleton EK, Littenberg B. "Magnesium intake and depression in adults." J Am Board Fam Med. 2015;28(2):249-256. doi: 10.3122/jabfm.2015.02.140176

38. Rajizadeh A, et al. "Effect of magnesium supplementation on depression status in depressed patients with magnesium deficiency." 2017.

39. Khan AM, Lubitz SA, Sullivan LM, et al. "Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study." Circulation. 2013;127(1):33-38. doi: 10.1161/CIRCULATIONAHA.111.082511

40. Adamopoulos C, Pitt B, Sui X, et al. "Low serum magnesium and cardiovascular mortality in chronic heart failure." Int J Cardiol. 2009;136(3):270-277. doi: 10.1016/j.ijcard.2008.05.006

41. Altman D, Carroli G, Duley L, et al. "Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial." Lancet. 2002;359(9321):1877-1890. doi: 10.1016/S0140-6736(02)08778-0

42. U.S. Department of Agriculture, FoodData Central. https://fdc.nal.usda.gov/

43. Moe SM. "Disorders involving calcium, phosphorus, and magnesium." Prim Care. 2008;35(2):215-237. doi: 10.1016/j.pop.2008.01.007

44. Grober U, Schmidt J, Kisters K. "Magnesium in Prevention and Therapy." Nutrients. 2015;7(9):8199-8226. doi: 10.3390/nu7095388

45. U.S. Food and Drug Administration. "FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)." March 2, 2011. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-low-magnesium-levels-can-be-associated-long-term-use-proton-pump